- Home
- XRTX vs ZNB Comparison
XRTX vs ZNB Comparison
Compare XRTX & ZNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XRTX | ZNB |
|---|---|---|
| Founded | 2011 | 2002 |
| Country | Canada | China |
| Employees | N/A | 14 |
| Industry | Pharmaceuticals and Biotechnology | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3M | 4.1M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | XRTX | ZNB |
|---|---|---|
| Price | $2.00 | $1.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 22.2K |
| Earning Date | 05-15-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.35 | $0.10 |
| 52 Week High | $3.60 | $9.78 |
Technical Indicators
Market Signals| Indicator | XRTX | ZNB |
|---|---|---|
| Relative Strength Index (RSI) | 41.83 | 45.92 |
| Support Level | $0.41 | $1.49 |
| Resistance Level | $3.03 | $1.90 |
| Average True Range (ATR) | 0.24 | 0.12 |
| MACD | -0.15 | 0.00 |
| Stochastic Oscillator | 4.49 | 34.37 |
Price Performance
Historical ComparisonAbout XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.
About ZNB Zeta Network Group Class A Ordinary Shares
Zeta Network Group is an entertainment technology company with a network that focuses on the application of technology and artificial intelligence in the entertainment industry. It provides online entertainment performances and online education through its wholly-owned subsidiaries Color Metaverse and CACM. The curriculum developed by the company includes music, sports, animation, painting and calligraphy, film and television, and life skills, covering various aspects of entertainment, sports, and culture.